FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097941 [Registered on: 24/11/2025] Trial Registered Prospectively
Last Modified On: 18/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A study on the effectiveness of homoeopathic medicines in managing bipolar disorder 
Scientific Title of Study   A Randomised control study to determine the effectiveness of homoeopathic polycrest remedies in the treatment of bipolar disorder with conventional therapy 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Rupali 
Designation  PG scholar 
Affiliation  Sri Ganganagar Homoeopathic Medical College Hospital And Research Centre 
Address  Near Riico Chownk Hanumangarh Road Sri Ganganagar Psychiatry Department Ground Floor

Ganganagar
RAJASTHAN
335002
India 
Phone  8735940000  
Fax    
Email  rup6781@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Shalu munjal  
Designation  Guide  
Affiliation  Sri Ganganagar Homoeopathic Medical College Hospital And Research Centre 
Address  Near Riico Bus Stand Hanumangarh Road SriGanganagar

Ganganagar
RAJASTHAN
335002
India 
Phone  9660019001  
Fax    
Email  drsunilbishnoi84@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Rupali 
Designation  PG Scholar 
Affiliation  Sri Ganganagar Homoeopathic Medical College Hospital And Research Centre 
Address  Near Riico Bus Stand Hanumamgarh Road Sri Ganganagar Psychiatry Department Ground Floor

Ganganagar
RAJASTHAN
335002
India 
Phone  8735940000  
Fax    
Email  rup6781@gmail.com  
 
Source of Monetary or Material Support  
nil 
 
Primary Sponsor  
Name  Tantia university  
Address  Sri Ganganagar Homoeopathic Medical College Hospital And Research Centre Near Riico Bus Stand Hanumamgarh road Sri ganganagar  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Rupali  Sri Ganganagar Homoeopathic Medical College Hospital And Research Institute  Near Riico Bus Stand Hanumamgarh Road Sri Ganganagar
Ganganagar
RAJASTHAN 
08735940000

rup6781@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Sri Ganganagar Homoeopathic Medical College Hospital And Research Centre Sri Ganganagar Homoeopathic Medical College Hospital And research institute  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F99||Mental disorder, not otherwise specified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathy  Homoeopathic polycrest remedies Starting with small dosage 30 potency and increasing it to 200 potency depending upon the severity of the symptoms Route of administration will be oral  
Comparator Agent  not applicable  not applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1.Patient aged 18 to 50 years with clinically diagnosed with bipolar disorder
2.Diagnosed bipolar disorder under stable conventional therapy for at least one month
3.willingness to participate and provide informed consent 
 
ExclusionCriteria 
Details  1.Comorbid severe psychiatric or neurological disorders
2.History of substance abuse
3.Current Homeopathic treatment
4.Preganant and lactating individuals 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Change in severity of bipolar symptoms by a standardized clinical scale(Bipolar spectrum diagnostic scale)  Baseline and end of intervention
3 weeks 6 weeks 9 weeks and 12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in quality of life scores as assessed by bipolar spectrum diagnostic scale  Baseline end of intervention
3weeks 6weeks 9weeks 12weeks 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   not yet recruiting 
Close